5AM Ventures II LP
Insider CIK 1386509 · RLYP 10% owner · FLXN 10% owner · SKYE 10% owner · PLCSD 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 114,851 | $1.61 | $184.9K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 4,528 | $1.61 | $7.3K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 4,528 | $1.61 | $7.3K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-23 | 2026-09-24 | 114,851 | $1.61 | $184.9K | 0 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 27,612 | $1.65 | $45.6K | 114,851 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 1,088 | $1.65 | $1.8K | 4,528 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 1,088 | $1.65 | $1.8K | 4,528 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-22 | 2026-09-24 | 27,612 | $1.65 | $45.6K | 114,851 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 32,607 | $1.91 | $62.3K | 142,463 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 1,285 | $1.91 | $2.5K | 5,616 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 1,285 | $1.91 | $2.5K | 5,616 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-09-16 | 2026-09-18 | 32,607 | $1.91 | $62.3K | 142,463 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 1,159 | $0.32 | $371 | 1,400,560 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 6,495 | $0.32 | $2.1K | 7,850,155 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 46 | $0.32 | $15 | 55,208 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 6,495 | $0.32 | $2.1K | 7,850,155 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 46 | $0.32 | $15 | 55,208 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-20 | 2026-08-20 | 1,159 | $0.32 | $371 | 1,400,560 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 409 | $0.35 | $143 | 55,254 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 57,476 | $0.35 | $20.1K | 7,856,650 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 10,255 | $0.35 | $3.6K | 1,401,719 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 57,476 | $0.35 | $20.1K | 7,856,650 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 409 | $0.35 | $143 | 55,254 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-19 | 2026-08-20 | 10,255 | $0.35 | $3.6K | 1,401,719 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 253,080 | $0.38 | $96.2K | 7,914,126 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,830 | $0.38 | $695 | 55,663 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 45,090 | $0.38 | $17.1K | 1,411,974 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 253,080 | $0.38 | $96.2K | 7,914,126 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 1,830 | $0.38 | $695 | 55,663 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2026-08-18 | 2026-08-20 | 45,090 | $0.38 | $17.1K | 1,411,974 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-22 | 2025-08-22 | 163,979 | $3.42 | $560.8K | 1,457,064 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-22 | 2025-08-22 | 6,470 | $3.42 | $22.1K | 57,493 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 2,314 | $3.57 | $8.3K | 63,963 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2025-08-21 | 2025-08-22 | 58,642 | $3.57 | $209.4K | 1,621,043 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 79 | $6.06 | $479 | 66,277 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 2,000 | $6.06 | $12.1K | 1,679,685 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-13 | 2024-09-13 | 11,758 | $6.06 | $71.3K | 8,167,206 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 36,504 | $6.60 | $240.9K | 1,681,685 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 214,556 | $6.60 | $1.42M | 8,178,964 | SEC↗ |
| SKYE Skye Bioscience, Inc. | S Sale | 2024-09-11 | 2024-09-13 | 1,440 | $6.60 | $9.5K | 66,356 | SEC↗ |
| SKYE Skye Bioscience, Inc. | P Buy | 2024-03-13 | 2024-03-15 | 450,000 | $10.00 | $4.50M | 8,393,520 | SEC↗ |
| SKYE Skye Bioscience, Inc. | P Buy | 2024-01-31 | 2024-02-02 | 5,206,074 | $2.31 | $12.03M | 7,943,520 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy | 2015-05-14 | 2015-05-29 | 25,649 | $0.37 | $9.5K | 288,447 | SEC↗ |
| VIVMF VIVEVE MEDICAL, INC. | P Buy | 2015-05-14 | 2015-05-29 | 650,026 | $0.37 | $240.5K | 7,310,231 | SEC↗ |
| PLCSD VIVEVE MEDICAL, INC. | P Buy | 2014-09-23 | 2014-09-25 | 5,017,677 | $0.53 | $2.66M | 6,660,205 | SEC↗ |
| PLCSD VIVEVE MEDICAL, INC. | P Buy | 2014-09-23 | 2014-09-25 | 197,987 | $0.53 | $104.9K | 262,798 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-16 | 2014-09-17 | 589,288 | $26.03 | $15.34M | 1,269,398 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-09-16 | 2014-09-17 | 23,252 | $26.03 | $605.2K | 50,082 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-26 | 2014-08-27 | 3,656 | $26.53 | $97.0K | 73,334 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-26 | 2014-08-27 | 92,654 | $26.53 | $2.46M | 1,858,686 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-25 | 2014-08-27 | 323,909 | $26.50 | $8.58M | 1,951,340 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2014-08-25 | 2014-08-27 | 12,781 | $26.50 | $338.7K | 76,990 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 1,693,249 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion deriv | 2014-02-18 | 2014-02-20 | 10,499,946 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 208,272 | — | $0 | 1,512,076 | SEC↗ |
| FLXN Flexion Therapeutics Inc | C Conversion | 2014-02-18 | 2014-02-20 | 1,291,505 | — | $0 | 1,303,804 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 8,181 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 22,765 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 15,260 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 29,876 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 47,849 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 207,347 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 576,958 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 386,754 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 757,187 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 676 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 676 | — | $0 | 676 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 676 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 2,931 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 2,931 | — | $0 | 2,931 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 2,931 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 1,461 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 1,461 | — | $0 | 1,461 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 994 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 17,141 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 17,141 | — | $0 | 17,141 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 17,141 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 74,281 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 74,281 | — | $0 | 74,281 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 74,281 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | M Exercise deriv | 2013-11-20 | 2013-11-20 | 37,056 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 37,056 | — | $0 | 37,056 | SEC↗ |
| RLYP Relypsa Inc | J Other deriv | 2013-11-20 | 2013-11-20 | 25,208 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion deriv | 2013-11-20 | 2013-11-20 | 1,888 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 1,888 | — | $0 | 85,980 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 8,181 | — | $0 | 84,092 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 22,765 | — | $0 | 75,911 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 22,432 | — | $0 | 53,146 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 29,876 | — | $0 | 30,714 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 269 | $11.00 | $3.0K | 2,275,248 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 17,141 | $0.17 | $2.9K | 2,275,517 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 1,162 | $11.00 | $12.8K | 2,258,376 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 74,281 | $0.17 | $12.6K | 2,259,538 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 30,942 | $11.00 | $340.4K | 2,185,257 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 37,056 | $9.18 | $340.2K | 2,216,199 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 47,849 | — | $0 | 2,179,143 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 207,347 | — | $0 | 2,131,294 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 576,958 | — | $0 | 1,923,947 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 568,542 | — | $0 | 1,346,989 | SEC↗ |
| RLYP Relypsa Inc | C Conversion | 2013-11-20 | 2013-11-20 | 757,187 | — | $0 | 778,447 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 11 | $11.00 | $121 | 89,771 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 676 | $0.17 | $115 | 89,782 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 46 | $11.00 | $506 | 89,106 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 2,931 | $0.17 | $498 | 89,152 | SEC↗ |
| RLYP Relypsa Inc | F Tax w/h | 2013-11-20 | 2013-11-20 | 1,220 | $11.00 | $13.4K | 86,221 | SEC↗ |
| RLYP Relypsa Inc | M Exercise | 2013-11-20 | 2013-11-20 | 1,461 | $9.18 | $13.4K | 87,441 | SEC↗ |